Erring drug companies to face stricter action as rules to improve mfg standards come into effect today

Drugmakers in India may soon face stricter enforcement of quality standards. The revised Schedule M, which details manufacturing practices and quality requirements, will come into effect on January 1. The industry had expected an extension but must now comply. The enforcement includes audits and risk-based inspections to ensure compliance with the new standards.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/6A5mI4D
via IFTTT

Read More

IBC turns lifeline for hospitals: Investors snap up distressed healthcare firms

Promoter-driven firms and hospital operators are targeting stressed healthcare assets through insolvency processes due to lower valuations. Despite risks, the post-pandemic interest in healthcare is high, driven by insurance penetration and government schemes, leading to significant acquisitions and resolution cases.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/sqRwNmy
via IFTTT

Read More

#25 For 2025: What will it take to ease the pain of medical inflation and rising premium payments?

Health insurance premiums are projected to rise by 10-15% in 2025 due to increasing medical costs, higher claims frequency, and regulatory changes. Medical inflation and increased hospital tariffs are pushing costs higher. Changes by IRDAI are making health insurance more accessible but adding strain to insurance finances. NHCX and billing practices need improvement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/tqzDMnY
via IFTTT

Read More

Will we succeed in making low medical bills a reality?

Healthcare costs are expected to decline over the next decade due to digital health platforms and cost-effective medical equipment. Indian pharmaceutical companies will increase production, while the insurance sector liberalization has allowed the launch of affordable health insurance. India is also set to become a major provider of healthcare professionals globally.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/V9sJOgv
via IFTTT

Read More

Why investing in healthcare is vital?

Technological advancements in cancer care offer immense investment potential in India, particularly in early detection and preventive solutions. Companies like Previu Health aim to transform diagnostics with their multi-cancer detection technology while expanding access and affordability nationwide, making healthcare investments both profitable and impactful.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/tMHQEzl
via IFTTT

Read More

Blackstone, Carlyle and other PEs submit bids to unlock Access' majority stake

Several global private equity funds, including Blackstone and Carlyle, have expressed interest in acquiring a majority stake in Access Healthcare. The company, specializing in revenue cycle management services, is expected to be valued at $1.4-1.5 billion. Access Healthcare, founded by Anurag Jain, employs 27,000 people globally.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/M54OBjw
via IFTTT

Read More

Home delivery of medicines from Railway-run hospitals in works

Indian Railways is planning to work with online pharmacy platforms to enable home delivery of medicines from its hospitals. RailTel aims to invite bids in January 2025 for discount-based services. This initiative, in collaboration with the health ministry, could extend to all government hospitals if successful.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/eTgLGbf
via IFTTT

Read More